Confirmatory large-scale trials are essential to ascertain the potential efficacy of GLP-1RAs in specifically improving the stroke outcomes
doi:10.1161/01.CIR.0000158487.80483.09 Shen X, Zheng S, Metreveli NS, Epstein PN
In absolute terms, about 8.0% of people in the semaglutide group experienced a major cardiovascular event compared with 9.8% in the placebo group
The GLP-1 injection guide and best injection sites for GLP-1 can help make injections less intimidating for those considering the switch, but the reality is that some people will always prefer an oral option regardless of convenience differences
Lean muscle during weight loss
The phase 3 ATTAIN-1 trial compared results for 3127 adult participants with obesity, or who were overweight with a weight-related medical problem, and who did not have diabetes